Medical White Papers are in-depth articles aimed to educate and inform site visitors interested in medical research. Some of these papers are derived from sources where we have existing commercial relationships. Such articles are clearly labelled as sponsored content and are only accepted when the content is deemed to add value to the core editorial ethos of News Medical.
Hospital waste varies from site to site and the biggest challenge is to dispose of this wide range of waste streams using one solution. Incineration is still the preferred way to process Type I to Type IV waste without endangering the health of patients, staff or anyone else coming into contact with them.
In this article, Sartorius answers 18 common questions about the new European Pharmacopoeia regulations - Chapter 2.1.7 “Balances for analytical purposes.”
In recent years, products containing Cannabidiol (CBD) have become increasingly popular, from chocolates to oils. In this article, LECO uses GCxGC-MS analysis to characterize beverage products containing CBD and explain the science behind it.
This article details how Cerba Research makes use of its extensive network of highly qualified professionals and state-of-the-art equipment to expertly develop companion diagnostic tests that allow clients to gauge the safety of a specific product.
Clinical trials heavily rely on routine testing. Cerba Research's broad portfolio offers a wide range of evaluations in hematology, biochemistry, serology, and urinalysis.
The emergence of new COVID-19 variants has required labs to adopt a much more systematic approach when it comes to large-scale vaccination. Cerba Research is a leader in NGS sequencing and has worked to reduce turnaround times and offer rapid response to any sequencing-related needs.
Immuno-oncology is a booming sector where insights need to be generated and analyzed as early as possible to optimize procedures. Cerba Research shares the three critical central lab capabilities to look for in a partner lab to achieve these results.
This article underlines how Cerba Research uses its network of highly-qualified professionals and state-of-the-art equipment to boost research on inflammatory and autoimmune diseases.
As the need for personalized medicine is made more apparent by the inefficiency of some treatments
against particular illnesses, biomarkers are offering benefits in the drug development process that cannot be overlooked. Cerba aims at delivering full repertoire of next-generation assays to make clinical trials and research easier.
Immuno-oncology is a promising cancer treatment approach that relies on immune regulation. It is particularly interesting as it could offer solutions for cancers that resist other forms of treatment. Cerba's laboratories and overall expertise and experience put them at the forefront of immuno-oncology research and trials.
Cerba's mission is to help improve clinical trials, but the ultimate goal is to make patients' lives easier. We are striving for safer, more comfortable processes to relieve patients of unnecessary stress, and that has been at the heart of Cerba's approach from the very first day.
Immuno-oncology (IO) trials can be a great chance for participating patients to fight cancer, but the
complex logistics behind them can prove difficult for the patient. Cerba Research partners with the
Gustave Roussy Institute to change the patients' journey and improve overall experience.
Immunotherapies are extremely promising areas of research, as they could provide a cancer treatment
that does not require surgery or radiation. Flow cytometry is used in immunotherapy research to measure and monitor immune responses.
The need for precision medicine and personalized medicine becomes clearer everyday as the inefficiency rate of some therapeutics is made apparent. Biomarkers hold the key to more efficient, more successful drug development and can remedy this issue.
Cerba Research have 25 years of extensive expertise in providing Phase I to Phase III flow cytometry
testing for clinical trials, and are proud of a strong track record of developing custom-made flow
Cerba Research offers flexible, customized solutions to successfully complete any complex clinical trials, thanks to an extensive network of professionals. Cerba offers in-vitro diagnostics to boost and optimize client trials and your testing potential.
For over 35 years, Cerba Research has excelled at delivering rapid, flexible support to clinical trials and more all over the world. From logistics to data management, high-end operational support is key for Cerba and its partners.
Rare diseases can be especially difficult to research - be it because of staff shortages or access to remote sites. Cerba Research and Cerba Healthcare are leaders in complex clinical trials and offer access to research AI, global data, and a network of highly qualified specialists that can assist with any kind of research.
Histopathology is undergoing rapid innovations due to the rise of precision medicine. Cerba's highly
sophisticated services and techniques in digital imaging are already assisting numerous partners to
enhance drug development.
This article outlines how Cerba Research U.S benefited from moving their Center of Excellence to a larger facility.